Efficacy and safety of antidepressants for children and adolescents (Q34546991)

2 August 2017

1 reference

title

Efficacy and safety of antidepressants for children and adolescents. (English)

1 reference

2 August 2017

1 reference

Jon N Jureidini

1

1 reference

2 August 2017

Christopher J Doecke

2

1 reference

2 August 2017

Peter R Mansfield

3

1 reference

2 August 2017

Michelle M Haby

4

1 reference

2 August 2017

David B Menkes

5

1 reference

2 August 2017

Anne L Tonkin

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

2 August 2017

1 reference

2 August 2017

328

1 reference

2 August 2017

879-883

1 reference

2 August 2017

7444

1 reference

Active placebos versus antidepressants for depression

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Facing the evidence: antidepressant treatment in children and adolescents

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Antidepressants and adverse effects in young patients: uncovering the evidence.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Concomitant psychotropic medication for youths

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Clinical practice guidelines for depression in young people: are the treatment recommendations outdated?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Timing of new black box warnings and withdrawals for prescription medications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Placebos, drug effects, and study design: a clinician's guide

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

St John's wort, conventional medication, and placebo: an egregious double standard.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Psychopharmacological treatment of major depressive disorder in children and adolescents

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Paroxetine in major depression

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Expectations and the placebo effect in clinical drug trials: why we should not turn a blind eye to unblinding, and other cautionary notes.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=387483

Clinician, Parent, and Child Prediction of Medication or Placebo in Double-Blind Depression Study

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15073072

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Venlafaxine in the treatment of children and adolescents with major depression

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15073072

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.328.7444.879

1 reference

2 August 2017

1 reference

2 August 2017

1 reference